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he appearance of protein aggregates is a charac-
teristic of protein misfolding disorders including
familial amyotrophic lateral sclerosis, a neuro-
degenerative  disease caused by inherited mutations in
Cu/Zn superoxide dismutase 1 (SOD1). Here, we use live
cell imaging of neuronal and nonneuronal cells to show
that SOD1 mutants (G85R and G93A) form an aggre-
gate structure consisting of immobile scaffolds, through
which noninteracting cellular proteins can diffuse. Hsp70
transiently interacts, in a chaperone activity-dependent
manner, with these mutant SOD1 aggregate structures.
T
 
In contrast, the proteasome is sequestered within the ag-
gregate structure, an event associated with decreased
degradation of a proteasomal substrate. Through the
use of time-lapse microscopy of individual cells, we show
that nearly all (90%) aggregate-containing cells express
higher levels of mutant SOD1 and died within 48 h,
whereas 70% of cells expressing a soluble mutant SOD1
survived. Our results demonstrate that SOD1 G85R and
G93A mutants form a distinct class of aggregate struc-
tures in cells destined for neuronal cell death.
 
Introduction
 
Familial amyotrophic lateral sclerosis (fALS) is a neurodegen-
erative disorder resulting in the selective loss of motor neurons
(Cleveland and Rothstein, 2001; Bruijn et al., 2004). Although
a number of genetic defects have been linked to the develop-
ment of fALS, the autosomal-dominant inheritance of mutant
Cu/Zn superoxide dismutase 1 (SOD1) accounts for 
 
 
 
20% of
cases (Rosen et al., 1993). Although numerous potential mech-
anisms of cytotoxicity have been proposed, including the de-
pletion of molecular chaperones, sequestration and dysfunction
of the proteasome, impairment of axonal transport, aberrant
dismutase activities, and mitochondrial disruption by SOD1
mutations (Bruijn et al., 2004), the contribution of each pro-
posed mechanism remains unclear. Although more than 100
different SOD1 mutations cause fALS, some of which retain
complete enzymatic activity (Borchelt et al., 1994; Bowling et
al., 1995; Gaudette et al., 2000), it has been well established
that mutant SOD1-mediated toxicity is caused by a toxic gain-
of-function rather than the loss of SOD1 activity (Bruijn et al.,
1998, 2004; Cleveland and Rothstein, 2001). A common fea-
ture, shared by most SOD1 mutations both in mutant SOD1
transgenic mouse models (Bruijn et al., 1997; Johnston et al.,
2000; Watanabe et al., 2001; Wang et al., 2002) and in tissue
samples from fALS patients (Shibata et al., 1996; Kato et al.,
2000), is the appearance of intracellular inclusions containing
detergent-insoluble protein aggregates. Such proteinacious in-
clusions also occur in many other neurodegenerative disorders
(Taylor et al., 2002) and their presence suggests an inability of
the protein quality control machinery (including molecular
chaperones and the ubiquitin–proteasome system) to efficiently
recognize, fold, and degrade this class of abnormal proteins
(Kopito, 2000; Goldberg, 2003). Association of the protea-
some, various molecular chaperones (i.e., Hsp40 and Hsp70),
and other cellular proteins including transcription factors with
aggregates (Bence et al., 2001; Watanabe et al., 2001; Kim et
al., 2002; Takeuchi et al., 2002; Holmberg et al., 2004; Bennett
et al., 2005) has been proposed as a common mechanism for
aggregate-associated cytotoxicity (Cleveland and Rothstein,
2001; Sherman and Goldberg, 2001; Taylor et al., 2002; Gold-
berg, 2003; Bruijn et al., 2004).
The role of aggregates in cytoprotection or cytotoxic-
ity of neuronal cell dysgenesis is a point of some contro-
versy. Some studies have shown no correlation between poly-
glutamine-containing aggregates and increased cell death (Saudou
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et al., 1998; Zhou et al., 2001; Arrasate et al., 2004) whereas
other studies have identified a direct relationship between ag-
gregates and cellular toxicity (Nucifora et al., 2001; Wyt-
tenbach et al., 2001; Jiang et al., 2003; Schaffar et al.,
2004). Whether this controversy is due to biologically relevant
differences associated with specific features of an aggregation-
prone protein or technical differences (i.e., level of protein
overexpression, cell type, method of detection/characteriza-
tion) is unclear. The absence of a uniform definition for an
aggregate or inclusion body may further contribute to such dif-
ferences. Cell biological studies have typically used visual
inspection and immunolocalization using fixed cells, comple-
mented by biochemical methods that detect insoluble proteins
using PAGE or a filter-trap assay of cell extracts. Other meth-
ods using fixed cells have used immunohistochemistry analysis
and electron microscopy to visualize aggregate and inclusion
structures at higher resolution (Bruijn et al., 1997, 1998). From
such approaches, aggregates formed by expression of either
mutant SOD1 or huntingtin have been suggested to have simi-
lar morphologies and structure. However, the recent applica-
tions of dynamic live cell imaging techniques (i.e., fluorescent
loss in photobleaching [FLIP], and fluorescence resonance en-
ergy transfer [FRET]) have revealed unexpected differences in
the aggregate structure of the polyglutamine proteins, ataxin 1
and mutant huntingtin (Chai et al., 2002; Kim et al., 2002;
Stenoien et al., 2002; Holmberg et al., 2004), leading to the
suggestion that other neurodegenerative disease-associated
proteins might also form distinct classes of aggregates.
In this study, we assess the composition and dynamic
properties of aggregates formed by G85R and G93A, two well-
characterized mutant SOD1 proteins, to gain insight into the
mechanistic events associated with SOD1 aggregate formation
and cytotoxicity. Using live-cell imaging of individual PC12
neuronal and HeLa cells, we find that mutant SOD1 proteins
form aggregates containing two distinct populations of protein,
one highly aggregated and immobile forming a scaffold, and a
second population mobile and diffusing within cavities present
throughout the immobile scaffold. Additionally, in vivo these
aggregates recruit, sequester, and decrease activity of the pro-
teasome. In contrast, the molecular chaperone Hsp70 interacts
transiently with mutant SOD1 aggregates. Using an automated
time-lapse imaging technique to follow the fate of individual
PC12 cells, we find that aggregate formation is lethal to the
cell. These studies reveal that the aggregate structures formed
by mutant SOD1 proteins, distinct from previously observed
aggregates formed by other misfolded proteins, are associated
with decreased cell survival.
 
Results
 
Mutant SOD1 forms aggregates 
containing mobile and immobile fractions
 
We monitored the in vivo dynamics of wild-type (WT) and
mutant SOD1 proteins, as well as their molecular interactions
in differentiated PC12 neuronal cells and HeLa cells, by express-
ing CFP and YFP fusions with WT (WT-CFP and WT-YFP)
and mutant (G85R-CFP, G85R-YFP, G93A-CFP, G93A-YFP)
SOD1 proteins. WT, G85R, and G93A fused to CFP (Fig. 1 A)
or YFP (unpublished data) accumulated to equivalent levels in
transiently transfected PC12 cells and both mutant proteins
were detected as full-length products of expected molecular
Figure 1. Mutant SOD1 forms aggregates containing mobile and immobile
fractions. (A–H) Differentiated PC12 cells were transiently transfected for
3 d with constructs encoding WT-CFP/YFP, G85R-CFP/YFP, or G93A-
CFP/YFP, as indicated. (A) Western analysis of SOD1 proteins. Whole
cells extracts were harvested and analyzed by Western analysis. CFP-
tagged proteins were detected with an anti-GFP antibody and  -tubulin
was used as a loading control. G85R migrates slightly faster than WT and
G93A, as previously described (Bruijn et al., 1998). The anti-GFP anti-
body detects no obvious free CFP molecules. (B) SOD1 activity assay.
Whole cell extracts were subjected to native-PAGE and SOD1 activities
were detected by NBT-negative staining. The activities of both transfected
and endogenous SOD1 are detected, as indicated. (C) Visualization of
SOD1 proteins. CFP fusion proteins (CFP, cyan) were visualized by confo-
cal microscopy and phase contrast microscopy (DIC). White arrows indi-
cate aggregates. Images have been cropped to enlarge the cell body; an
image showing neurites, a marker for neuronal differentiation, is found in
Fig. S1. (D) Filter trap assay of SOD1 proteins. Whole cell extracts were
treated with 1% SDS and subjected to filter trap analysis on a cellulose
acetate membrane. Proteins that are retained on the membrane were de-
tected with an anti-GFP antibody. (E) FRAP analysis of SOD1 proteins.
Single scan images were obtained before photobleaching (Pre) of a region
of interest (ROI; white box) and at the indicated times after photobleaching.
Arrows indicate the photobleached area. Note that the intensity of the im-
ages is scaled differently between the samples. (F) Quantitative FRAP anal-
ysis of SOD1 proteins. The relative fluorescence intensity (RFI) was deter-
mined at each time point and is represented as the mean   SEM (n   10
cells). (G) FLIP analysis of SOD1 proteins. Single scan images of a diffuse
(open arrow) and aggregated region (closed arrow) were obtained be-
fore (Pre) and at the indicated times during continuous photobleaching of
a region (white box). (H) Quantitative FLIP analysis of SOD1 proteins. The
RFI was determined at each time point and is represented as the mean  
SEM (n   5–10 cells). Bars, 10  m. 
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sizes. A similar level of protein accumulation was also detected
in HeLa cells (unpublished data). WT-CFP and G93A-CFP dis-
played SOD1 enzymatic activity and inhibited the reduction of
nitroblue tetrazolium (NBT) by superoxide, whereas G85R-
CFP did not exhibit detectable SOD1 activity (Pasinelli et al.,
1998) in either PC12 (Fig. 1 B) or HeLa cells (unpublished
data). The subcellular localization of WT-CFP, G85R-CFP,
and G93A-CFP was visualized in differentiated PC12 (Fig. 1 C)
and HeLa cells (Fig. S1 available at http://www.jcb.org/cgi/
content/full/jcb.200504050/DC1). Neuronal processes, charac-
teristic of differentiated PC12 cells, are not apparent in these
images and are visualized at lower magnification (Fig. S1).
WT-CFP exhibited a diffuse pattern of protein localization
throughout the cell, whereas large perinuclear aggregates were
detected in cells expressing G85R-CFP and G93A-CFP. As a
complement to the visual identification of aggregates, we per-
formed a cellulose acetate filter retardation assay (Wanker et
al., 1999; Wang et al., 2002). Whereas WT-CFP was soluble,
both mutant proteins were trapped as 1% SDS-insoluble spe-
cies, in PC12 (Fig. 1 D) and HeLa cells (unpublished data), in-
dicative of aggregate formation (Wanker et al., 1999; Wang et
al., 2002). From these results, we conclude that both mutant
SOD1-YFP/CFP proteins exhibit a similar aggregation pheno-
type, whether expressed in PC12 neuronal cells or HeLa cells.
To investigate the mobility of diffuse and aggregated
SOD1 proteins, we performed qualitative and quantitative
FRAP analysis in PC12 cells (Lippincott-Schwartz et al.,
2001). Compared with WT-YFP and the diffusely localized
G85R-YFP and G93A-YFP proteins, which were com-
pletely mobile, aggregated G85R-YFP and G93A-YFP proteins
showed dramatically reduced mobility (Fig. 1, E and F, and
Table I). Unexpectedly, the pattern of fluorescence recovery
within either mutant SOD1 aggregate was not consistent with
the presence of a single protein population, as reported with ag-
gregates formed by the mutant huntingtin protein (Kim et al.,
2002; Holmberg et al., 2004). The FRAP data suggested that
both G85R and G93A mutant SOD1 aggregates are comprised
of two protein populations. Mathematical analyses of FRAP
data indeed supported these assertions, as both curves fit to a
recovery consistent with two populations (see Materials and
methods). An immobile (nondiffusing) protein population,
with off-rates 
 
 
 
0.001 s
 
 
 
1
 
, predominated and accounted for
76.8 
 
 
 
 1.9% (G85R-YFP) and 61.6 
 
 
 
 2.2% (G93A-YFP) of
total fluorescent protein within the aggregates (Fig. 1, E and F,
and Table I). These fractions remained immobile even when the
analysis was extended to a 10-min period (unpublished data).
The presence of a slow off-rate and a persistent immobile popu-
lation reveals a long residency time (
 
 
 
r
 
 
 
 
 
 1,000 s) of mutant
SOD1 protein in this immobile form, corresponding to stable
SOD1 aggregate structures. In contrast, the remaining 23.2 
 
 
 
1.9% (G85R-YFP) and 38.4 
 
 
 
 2.2% (G93A-YFP) of protein
within each aggregate was diffused (Fig. 1, E and F, and Table I).
The “diffuse” fractions of the mutant SOD1 proteins are
not the same as the “diffuse” WT protein, as the diffusion coef-
ficients are 1.47 
 
 
 
m
 
2
 
/s (G85R-YFP) and 1.67 
 
 
 
m
 
2
 
/s (G93A-
YFP), compared with 2.35 
 
 
 
m
 
2
 
/s (WT-YFP; Table I). These
results together with additional analyses (see Materials and
methods) suggest that the diffuse G85R-YFP corresponds to
higher-order structures of approximate molecular weights of
250 kD. This could reflect the formation of oligomers of
G85R-YFP or the stable association of other cellular proteins
with G85R-YFP. These results suggest that mutant SOD1 may
form oligomers that are transiently diffuse, followed by higher-
order oligomerization and thus populations with slower diffu-
sion, and finally aggregation and immobilization (no diffu-
sion). Similar to differentiated PC12 cells, we observed that
both a diffuse and immobile (nondiffusing) fraction of protein
exist within mutant SOD1 aggregates in undifferentiated PC12
and HeLa cells (Fig. S1). From these results, we conclude that
both G85R-YFP and G93A-YFP form immobile aggregates;
however, differences in the fraction of each mutant SOD1 pro-
tein present in the aggregated state reveals subtle distinctions
between the two mutant proteins.
To test the hypothesis that two protein populations are
indeed present within the mutant SOD1 aggregates, we used a
complimentary imaging technique, FLIP. Fluorescence intensities
 
Table I. 
 
Quantitative FRAP analysis of YFP-tagged proteins
Sample Diffusing fraction D Nondiffusing fraction k
 
U
 
 
 
%
 
 
 
m
 
2
 
/s  % s
 
 
 
1
 
WT-YFP 95.0 
 
  
 
2.3 2.35 
 
  
 
0.60 5.0 
 
  
 
2.3 N/A
G85R-YFP diffuse 92.1 
 
  
 
3.1
 
ns,
 
 
 
a
 
1.67 
 
  
 
0.29 7.9 
 
  
 
3.1
 
ns,
 
 
 
a
 
0.013 
 
  
 
0.008
G93A-YFP diffuse 92.1 
 
  
 
2.9
 
ns,
 
 
 
a
 
1.47 
 
  
 
0.23 7.9 
 
  
 
2.9
 
ns,
 
 
 
a
 
0.011 
 
  
 
0.006
G85R-YFP aggregate 23.2 
 
  
 
1.9***
 
,
 
 
 
b
 
1.27 
 
  
 
0.72 76.8 
 
  
 
1.9***
 
,
 
 
 
b
 
 
 
0.001
G93A-YFP aggregate 38.4 
 
  
 
2.2***
 
,
 
 
 
b
 
0.88 
 
  
 
0.26 61.6 
 
  
 
2.2***
 
,
 
 
 
b
 
 
 
0.001
LMP2-YFP (diffuse G85R-CFP) 94.6 
 
  
 
2.8 2.20 
 
  
 
0.39 5.4 
 
  
 
2.8 0.012 
 
  
 
0.009
LMP2-YFP (G85R-CFP aggregate) 27.6 
 
  
 
1.2***
 
,
 
 
 
b
 
1.78 
 
  
 
0.50 72.4 
 
  
 
1.2***
 
,
 
 
 
b
 
 
 
0.001
Hsp70-YFP (diffuse G85R-CFP) 85.8 
 
  
 
1.9 1.76 
 
  
 
0.31 14.2 
 
  
 
1.8 0.008 
 
  
 
0.002
Hsp70-YFP (G85R-CFP aggregate) 65.2 
 
  
 
1.9***
 
,
 
 
 
b
 
1.07 
 
  
 
0.12 34.8 
 
  
 
1.9***
 
,
 
 
 
b
 
0.004 
 
  
 
0.001
Hsp70-SBDx-YFP (diffuse G85R-CFP) 92.6 
 
  
 
1.9 2***
 
,
 
 
 
c
 
1.93 
 
  
 
0.28 7.4 
 
  
 
1.9 2***
 
,
 
 
 
c
 
0.009 
 
  
 
0.006
Hsp70-SBDx-YFP (G85R-CFP aggregate) 76.4 
 
  
 
1.62***
 
,
 
 
 
c
 
2.13 
 
  
 
0.34 23.6 
 
  
 
1.62***
 
,
 
 
 
c
 
0.003 
 
  
 
0.001
 
FRAP data from Figs. 1F, 3B, and 4B were analyzed with GraphPad Prism software, as described in Supplementary Information, Methods online. Data are displayed
as mean 
 
 
 
 SEM. Two-tailed 
 
t
 
 test analysis (95% confidence) was used to compare the statistical difference between data sets: ***, P 
 
  
 
0.001; ns, P 
 
  
 
0.05. 
 
a
 
Diffuse G85R-YFP and G93A-YFP were compared to WT-YFP.
 
b
 
Samples were compared to the respective diffuse sample (i.e., G85R-YFP aggregated vs. G85R-YFP diffuse).
 
c
 
Hsp70-SBDx-YFP mutant samples were compared to the respective Hsp70-YFP sample (i.e., Hsp70-SBDx-YFP with diffuse G85R-CFP vs. Hsp70-YFP with diffuse G85R-CFP). 
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of G85R-YFP and G93A-YFP within and outside the aggregate
were measured while a region adjacent to the aggregate was
continuously photobleached. We expected that a fraction of
protein within the aggregate would remain intact while a sec-
ond population would diffuse out of the aggregate and become
photobleached. As with FRAP analyses, our FLIP data pre-
sented a better fit to a two-phase exponential decay curve, con-
firming the presence of two distinct populations of protein.
FLIP revealed that 45% (G85R-YFP) and 38% (G93A-YFP) of
the initial fluorescence within the aggregate persisted over a
10-min period (Fig. 1, G and H), supporting our hypothesis that
one population of mutant SOD1 protein forms a stable aggre-
gate structure. In contrast, the fluorescence intensities of WT-
YFP, as well as the diffusely localized G85R-YFP and G93A-
YFP proteins, were rapidly reduced and continued to decrease
to basal fluorescence after 10 min of continuous photobleach-
ing, indicative of a single mobile population (Fig. 1, G and H).
Together, the FRAP and FLIP analyses suggest that mutant
SOD1 (G85R and G93A) aggregates are composed of two pro-
tein populations, one mobile and diffusing and a second highly
immobile and aggregated population.
 
Mutant SOD1 aggregates form a 
disordered “honeycomb-like” porous 
structure
 
FRAP and FLIP analyses suggested that mutant SOD1 proteins
formed porous aggregate structures through which other solu-
ble cellular proteins may diffuse. This is in contrast to aggre-
gates formed by mutant huntingtin and polyglutamine-YFP
proteins, which we and others have shown form a solid and im-
mobile core structure (Chai et al., 2002; Kim et al., 2002;
Holmberg et al., 2004). To determine whether noninteract-
ing soluble proteins can indeed diffuse through the mutant
SOD1 aggregate structures, PC12 cells were transiently cotrans-
fected with a construct encoding an aggregation-prone protein
(G85R-CFP, G93A-CFP, or httQ78-CFP) and a soluble YFP or
WT-YFP. YFP (Fig. 2 A) and WT-YFP (Fig. S2 available at
http://www.jcb.org/cgi/content/full/jcb.200504050/DC1) pro-
teins displayed a diffuse and uniform pattern of localization,
both within and outside the mutant SOD1 aggregates. In con-
trast, aggregates formed by expression of an expanded poly-
glutamine-containing mutant huntingtin protein (httQ78-CFP)
exhibited a solid core that completely excluded YFP (Fig. 2 A).
These results suggested that soluble proteins can colocalize
with the aggregate structures formed by mutant SOD1.
Whereas standard colocalization methods do not establish
whether associated proteins are nonspecifically trapped or dif-
fuse within the aggregate, FLIP analysis provides a direct test,
as we would expect that soluble proteins can diffuse rapidly out
of the aggregate structures and become photobleached. The ini-
tial fluorescence intensities of YFP, either within or outside the
mutant SOD1 (G85R-CFP or G93A-CFP) aggregates, were
rapidly reduced and continued to decrease to basal fluorescence
after 10 min of continuous photobleaching (Fig. 2, B and C).
These results were similar to the diffusion of YFP alone, con-
firming that YFP molecules remain diffuse even when localized
within the mutant SOD1 aggregate structures. Experiments
performed in parallel revealed that WT-YFP molecules also
diffuse through the mutant SOD1 aggregate structures (Fig.
S2). These results support our hypothesis that mutant SOD1
proteins form porous, almost honeycomb-like aggregate struc-
tures, consisting of a highly immobile scaffold through which
soluble cellular proteins can diffuse.
 
Hsp70 transiently interacts with mutant 
SOD1 aggregates
 
Although noninteracting proteins diffuse rapidly through the
mutant SOD1 aggregate structures, we speculated that other
proteins, which interact with aggregates formed by neurode-
generative disease-associated proteins, would display reduced
mobility. To investigate the interaction of the molecular chap-
erone Hsp70 within the mutant SOD1 aggregates, PC12 cells
were transiently transfected with constructs encoding G85R-
CFP and a YFP-tagged Hsp70 (Hsp70-YFP) protein. This con-
struct has been previously used in our laboratory and retains its
Figure 2. Mutant SOD1 aggregates form a disordered honeycomb-like
porous structure. (A–C) Differentiated PC12 cells were transiently trans-
fected with constructs encoding YFP together with G85R-CFP, G93A-CFP,
or httQ78-CFP, as indicated. (A) Colocalization of YFP with G85R-CFP,
G93A-CFP, or httQ78-CFP aggregates. YFP (YFP, yellow) and CFP fusion
protein (CFP, cyan) were visualized by confocal microscopy and phase
contrast microscopy (DIC). Colocalization was illustrated by merging YFP
and CFP channels (Merge). Arrows indicate protein aggregates. (B and C)
Differentiated PC12 cells were transiently transfected with constructs encod-
ing YFP together with G85R-CFP or G93A-CFP, as indicated. (B) FLIP anal-
ysis of YFP. Single scan images of a diffuse (open arrow) and aggregated
region (closed arrow) were obtained before (Pre) and at the indicated
times during continuous photobleaching of a region (black box). (C) Quan-
titative FLIP analysis of YFP. The RFI was determined at each time point and
is represented as the mean   SEM (n   5–10 cells). Bars, 10  m. 
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activity as a molecular chaperone (Kim et al., 2002). FRAP
analysis showed that 85.8   1.9% of Hsp70-YFP was diffused
in cells expressing soluble G85R-CFP (Fig. 3, A and B, and
Table I). In contrast, in cells with G85R-CFP aggregates, 34.8  
1.9% of Hsp70-YFP was associated with the aggregates,
with the remaining Hsp70-YFP in a soluble state (Fig. 3, A and
B, and Table I). To address whether the association of Hsp70
reflected its chaperone function, we measured the mobility of a
mutant Hsp70-YFP containing a mutation in the substrate-
binding domain (Hsp70-SBDx-YFP). The mobility of Hsp70-
SBDx-YFP was higher than for Hsp70-YFP with aggregated
G85R-CFP (Fig. 3 B and Table I), revealing that a functional
Hsp70 chaperone cycle is required for the interaction between
Hsp70 and the aggregate. To further demonstrate that the Hsp70-
aggregate interaction was transient, we used FLIP analysis,
which showed that the fluorescence intensity of Hsp70-YFP
within G85R-CFP aggregates declined rapidly to basal levels
over a 10-min period of photobleaching (Fig. 3, C and D). From
the results of FRAP and FLIP analysis, we conclude that Hsp70
is not sequestered, rather it is associated transiently with aggre-
gate structures formed by mutant SOD1 proteins.
Mutant SOD1 aggregates sequester the 
proteasome and impair its activity
Aggregates formed by many neurodegenerative disease–asso-
ciated proteins, including mutant SOD1, have been shown to
interact with the proteasome (Bence et al., 2001; Urushitani et
al., 2002; Goldberg, 2003; Kabashi et al., 2004). To monitor in-
teractions between mutant SOD1 and the 20S proteasome, we
introduced a YFP-tagged   subunit (LMP2-YFP) into PC12
cells together with a construct encoding G85R-CFP. LMP2 is
quantitatively incorporated into active proteasomes and there-
fore provides an excellent indicator of the functional protea-
some (Reits et al., 1997; Holmberg et al., 2004). FRAP analysis
indicated that 94.1   3.3% of LMP2-YFP was diffuse in cells
containing diffusely localized G85R-CFP (Fig. 4, A and B, and
Table I). These results were similar to the previously reported
mobility of LMP2-GFP in cells expressing LMP2-GFP alone
(Reits et al., 1997) or in cells containing a diffusely localized
WT NH2-terminal huntingtin protein (Holmberg et al., 2004).
In aggregate-containing cells, the proteasome is relocalized to
aggregates, with 72.1   1.8% of the total LMP2-YFP immobi-
lized within the G85R-CFP aggregate with a slow off-rate  
0.001 s
 1 (Fig. 4, A and B, and Table I). The presence of a slow
off-rate reveals a long residency time ( r   1,000 s) for LMP2-
YFP in this immobile state suggesting a tight interaction with
the G85R-CFP aggregate.
To further establish the interaction of LMP2-YFP with
the G85R-CFP aggregate, we used FLIP analysis. FLIP showed
that 39.7   10.7% of the initial fluorescence intensity of LMP2-
YFP associated with G85R-CFP aggregates was retained after
a 10-min period of photobleaching (Fig. 4, C and D), suggest-
ing that the proteasome is sequestered within G85R-CFP ag-
gregates. To verify that these results reflect the endogenous
proteasome, we used indirect immunofluorescence analysis
and showed that the endogenous 20S subunit of the proteasome
is associated with G85R-CFP and G93A-CFP aggregates (Fig.
S3 available at http://www.jcb.org/cgi/content/full/jcb.200504050/
DC1). Taken together, these results demonstrate that the pro-
teasome is sequestered into the immobile fraction of the mutant
SOD1 aggregate structures.
We next examined whether sequestration of the protea-
some within the mutant SOD1 aggregate has negative conse-
quences on proteasome activity. To address this, we used an
Ubi-YFP reporter construct (Holmberg et al., 2004) that was
stably transfected into PC12 cells. The Ubi reporter consists
of ubiquitin followed by a 40–amino acid lysine-containing
linker region. The ubiquitin is rapidly cleaved off in vivo, pro-
moting ubiquitination of the internal lysine residues and foster-
ing degradation of the YFP-fusion protein by the proteasome.
Cells in which proteasomal activity is impaired will show an
accumulation of the Ubi-YFP protein. Differentiated Ubi-
YFP/PC12 cells were transiently transfected with WT-CFP,
G85R-CFP, or G93A-CFP. As a positive control, we tran-
siently transfected the Ubi-YFP/PC12 cells with a construct
encoding the mutant huntingtin protein (httQ78-YFP). Similar
Figure 3. Hsp70 transiently interacts with mutant SOD1
aggregates. Differentiated PC12 cells were transiently
transfected with constructs encoding Hsp70-YFP or
Hsp70-SBDx-YFP together with G85R-CFP, as indicated.
(A) FRAP analysis of Hsp70-YFP. Single scan images
were obtained before photobleaching (Pre) of a ROI
(white or black box) and at the indicated times after pho-
tobleaching. Arrows indicate the photobleached area. (B)
Quantitative FRAP analysis of Hsp70-YFP and Hsp70-
SBDx-YFP. The RFI was determined at each time point and
is represented as the mean   SEM (n   10 cells). (Inset)
The region of photobleaching recovery from 0 to 15 s is
shown for clarity. (C) FLIP analysis of Hsp70-YFP. Single
scan images of a diffuse (open arrow) and aggregated
region (closed arrow) were obtained before (Pre) and at
the indicated times during continuous photobleaching of
a region (white box). (D) Quantitative FLIP analysis of
Hsp70-YFP. The RFI was determined at each time point
and is represented as the mean   SEM (n   5–10 cells).
Bars, 10  m.JCB • VOLUME 171 • NUMBER 1 • 2005 80
to previous reports (Bence et al., 2001; Bennett et al., 2005),
we detected an increased level of Ubi-YFP accumulation (1.88  
0.23-fold increase; unpublished data) in cells containing
httQ78-CFP aggregates. Compared with cells expressing WT-
CFP or diffusely localized G93A-CFP, cells displaying a dif-
fuse G85R-CFP localization showed an increased accumulation
of Ubi-YFP (Fig. 4, E and F). A further and substantial en-
hancement in Ubi-YFP accumulation was observed in cells
containing aggregates formed by either G85R-CFP (2.90  
0.19-fold increase) or G93A-CFP (2.59   0.26-fold increase;
Fig. 4, E and F). These findings suggest that the formation of
mutant SOD1 aggregates is highly correlated with reduced in
vivo proteasome activity.
Cell death caused by mutant SOD1 
aggregates
To test whether aggregate formation is directly associated
with neuronal cell death, differentiated PC12 cells express-
ing YFP, WT-YFP, G85R-YFP, or G93A-YFP were fol-
lowed using live-cell time-lapse fluorescence microscopy.
Individual cells were monitored, during a 48-h period (days 3
to 5 after transfection) for protein accumulation, aggregate
appearance, and cell death, based on morphological change
or propidium iodide (PI) staining (Fig. 5 and Video S1 avail-
able at http://www.jcb.org/cgi/content/full/jcb.200504050/
DC1). Whereas WT-YFP-transfected cells did not form aggre-
gates, the percentage of cells expressing aggregated G85R-
YFP or G93A-YFP after 3 d of expression was 30 and 15%,
respectively. Within the ensuing 48-h period, 15.3   3.6%
of nontransfected PC12 cells and 14.5   3.5% of WT-
YFP–transfected cells underwent cell death, whereas  90%
(88.5   1.2% for G85R-YFP and 90.3   4.1% for G93A-
YFP) of cells expressing a mutant SOD1 aggregate subse-
quently died (Fig. 5 A).
An additional 30 (G85R-YFP) and 15% (G93A-YFP) of
cells, in which aggregates were initially not detected, formed
an aggregate during this 48-h monitoring period. We fol-
lowed the level of G85R-YFP accumulation (total YFP fluo-
rescence) before overt aggregate appearance in these cells
and compared it to G85R-YFP accumulation in cells without
aggregate appearance during this 48-h period (Fig. 5 B). As
aggregates appeared at varying times during this 48-h period,
the time-point of overt aggregate appearance was normalized
as the 48-h time-point. Certain cells maintained a constant
level of G85R-YFP protein reflecting a balance between syn-
thesis and degradation without detectable aggregate forma-
tion (Fig. 5 B), whereas other cells displayed an imbalance in
these processes, with a rapid increase in the level of mutant
SOD1 protein, followed by the formation of large, visible ag-
gregates (Fig. 5 B, aggregate formed). Furthermore, 70% of
these aggregate-forming cells died during the subsequent 48-h
monitoring period with the majority of these cells dying
within 6 to 24 h after initial aggregate appearance (Fig. 5 C).
In contrast, of the 30% of PC12 cells expressing diffuse mu-
tant SOD1 proteins that exhibited cell death, we did not ob-
serve the same striking correlation with cell death (Fig. 5 C).
Likewise, cells expressing soluble WT SOD1 did not un-
dergo cell death, thus ruling out negative effects due to a flux
of heterologous expression of SOD1 (Fig. 5 C). We conclude
from these time-lapse studies that there is a close correlation
between the appearance of mutant SOD1 aggregates, and
subsequent cell death.
Figure 4. Mutant SOD1 aggregates sequester the protea-
some and impair its activity. (A–D) Differentiated PC12 cells
were transiently transfected with constructs encoding LMP2-
YFP and G85R-CFP. (A) FRAP analysis of LMP2-YFP. Single
scan images were obtained before photobleaching (Pre) of a
ROI (white or black box) and at the indicated times after pho-
tobleaching. Arrows indicate the photobleached area. (B)
Quantitative FRAP analysis of LMP2-YFP. The RFI was deter-
mined at each time point and is represented as the mean  
SEM (n   10 cells). (C) FLIP analysis of LMP2-YFP. Single
scan images of a diffuse (open arrow) and aggregated re-
gion (closed arrow) were obtained before (Pre) and at the in-
dicated times during continuous photobleaching of a region
(white box). (D) Quantitative FLIP analysis of LMP2-YFP. The
RFI was determined at each time point and is represented as
the mean   SEM (n   5–10 cells). Note: 62.3   3.7% of to-
tal LMP2-YFP fluorescence intensity is associated with the
G85R-CFP aggregate (n   7 cells; see Materials and meth-
ods). (E and F) Stable differentiated Ubi-YFP/PC12 cells were
transiently transfected with constructs encoding WT-CFP,
G85R-CFP, or G93A-CFP. (E) Accumulation of a proteasomal
substrate. Ubi-YFP (YFP, yellow) and CFP fusion proteins
(CFP, cyan) were visualized by fluorescence microscopy. Mu-
tant SOD1 protein aggregates (closed arrows) and diffuse
SOD1 (open arrows) are indicated. (F) Quantification of Ubi-
YFP fluorescence. The fold increase of Ubi-YFP intensity com-
pared with the mean intensity of nontransfected cells is repre-
sented as the mean   SEM (n   28–56 cells). Bars, 10  m.
Two-tailed t test analysis (95% confidence) was used to com-
pare the statistical difference between data sets: ***, P  
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Discussion
In this study, we show that mutant G85R and G93A SOD1 pro-
teins form a novel class of aggregates that correlate with cell
death. Despite the difference in mutation type and in function,
we observed similar biophysical properties of the aggregate
species and toxicity. Using live-cell imaging, we observe that
both mutant SOD1 proteins form large perinuclear aggregates
that contain two populations; an immobile fraction organized
into an amorphous scaffold containing mutant SOD1 and other
cellular proteins such as the proteasome, and another popula-
tion of mobile (diffuse) protein including mutant SOD1 in a
soluble state and molecular chaperones. The structural charac-
teristics for mutant SOD1 aggregates described here are ob-
served in both neuronal (PC12) and nonneuronal (HeLa) cells,
suggesting that these features may reflect common intrinsic
properties associated with the expression of these mutant
SOD1 proteins, independent of cell type.
Our live-cell analyses suggest that, even though the mutant
SOD1 aggregate is structured, it is highly amorphous, with a dis-
ordered honeycomb-like scaffold through which other cellular
proteins readily diffuse. This is in contrast to the aggregate struc-
tures formed by mutant huntingtin or polyglutamine-YFP that
are immobile and densely packed, prohibiting the diffusion of
certain soluble proteins (Chai et al., 2002; Kim et al., 2002;
Holmberg et al., 2004). A third class of aggregate structures
formed by expression of the polyglutamine protein, ataxin-1, is
comprised of either fast or slow mobile components exchanging
between the aggregate and the nucleoplasm (Stenoien et al.,
2002). Taken together with our current results with mutant
SOD1, we conclude that mutant huntingtin, ataxin-1, and SOD1
form aggregates that appear fundamentally distinct in their orga-
nization and structure. The molecular characteristics that distin-
guish these three classes were revealed only by the use of dy-
namic live cell imaging methods. Whether these results can be
extrapolated to suggest an even more diverse family of in vivo
aggregate structures, remains a question to be addressed in future
studies on other neurodegenerative disease associated proteins.
Among the mechanisms proposed for aggregate-associ-
ated cytotoxicity is the association of cellular proteins with mis-
folded oligomers and aggregates (Bruijn et al., 1997, 2004;
Cleveland and Rothstein, 2001; Pasinelli et al., 2004). Poly-
glutamine aggregates have been shown to recruit and sequester
polyglutamine-containing transcription factors, such as TATA-
binding protein (TBP) and CREB-binding protein (Steffan et
al., 2000; Nucifora et al., 2001; Kim et al., 2002). The interac-
tion between TBP and polyglutamine aggregates is dependent
upon the presence of a polyglutamine stretch in TBP (Kim et al.,
2002); consistent with this is the lack of colocalization of TBP
with the mutant SOD1 aggregates (unpublished data). Another
commonly observed class of proteins associated with various
aggregates are components of the protein quality control ma-
chinery, including Hsp70 and the proteasome (Bence et al.,
2001; Cleveland and Rothstein, 2001; Watanabe et al., 2001;
Kim et al., 2002; Takeuchi et al., 2002; Urushitani et al., 2002;
Bruijn et al., 2004; Bennett et al., 2005; Holmberg et al., 2004;
Kabashi et al., 2004). Our results show that, while Hsp70 inter-
acts transiently with mutant SOD1 aggregates in a chaperone-
dependent manner, Hsp70 is not sequestered within the aggre-
gate, similar to what was observed with mutant huntingtin (Kim
et al., 2002). Likewise, both the endogenous proteasome and the
transiently transfected LMP2 proteasomal subunit interact with
the mutant SOD1 aggregate. However, FRAP and FLIP analy-
ses showed that the proteasome was sequestered irreversibly.
Figure 5. Cell death associated with mutant SOD1 aggregates. Differenti-
ated PC12 cells were transiently transfected with constructs encoding WT-
YFP, G85R-YFP, or G93A-YFP. (A) Cell death after SOD1 protein expres-
sion. Individual cells were followed for a 48-h period, from 3 to 5 d after
transfection, using time-lapse fluorescence microscopy. Cell death was cal-
culated as a percentage of dead cells at the end of the 48-h period, com-
pared with the total number of cells. Two-tailed t test analysis (95% confi-
dence) was used to compare the statistical difference between data sets:
***, P   0.001; *, P   0.05. (B) Intensity of G85R-YFP whole cell fluores-
cence. Whole cell fluorescence, from 3 to 5 d after transfection, was mea-
sured in PC12 cells transiently transfected with G85R-YFP. Fluorescence was
measured for each time frame (every 3 h). Completed aggregate formation
is set as the point of fluorescence saturation and then normalized as the 48-h
time-point. n   17 cells without aggregates and n   21 cells with aggre-
gates. (C) Life-time of cells after mutant SOD1 aggregate formation. Images
of individual cells were taken at 2 to 3 h intervals, during the 48-h period.
For cells forming visible aggregates, life-time was determined from the time
when aggregates appeared (t   0) to the time when cell death was ob-
served. For cells that underwent cell death without the presence of visual ag-
gregates, t   0 was determined 3 d after transfection corresponding to a
time when levels of mutant SOD1 RNA and protein levels were readily
detected. Normalized life-time, t   0 to cell death, were depicted against
the percentage of dead cells at the indicated times.JCB • VOLUME 171 • NUMBER 1 • 2005 82
Coincident with the sequestration of the proteasome within the
mutant SOD1 aggregate, we observe decreased proteasome ac-
tivity; however, our results do not establish whether proteasome
impairment occurred before or after the appearance of aggre-
gates. Whereas we observed a slight increase in Ubi-YFP accu-
mulation in cells expressing diffusely localized G85R-YFP, a
greater inhibitory effect on proteasome activity was observed in
cells with visible aggregates, similar to what has been observed
for mutant huntingtin (Bence et al., 2001; Bennett et al., 2005).
However, this contrasts with mutant ataxin-1 aggregates that do
not irreversibly sequester the colocalized proteasome (Stenoien
et al., 2002). We conclude that the biochemical properties of
each misfolded protein determine the intrinsic features of aggre-
gate structure, the nature of interactions with other cellular pro-
teins, and the dynamics of these interactions.
In our studies, mutant SOD1 aggregates localize near the
microtubule organizing centers and are surrounded by  -tubulin
(unpublished observations), consistent with previous studies
showing that mutant SOD1 forms aggresomes through a micro-
tubule-dependent process (Johnston et al., 1998, 2000; Kopito,
2000). Although aggresome formation may be a component of
the cellular response to the accumulation of misfolded proteins
when the capacity of the proteasome is exceeded (Kopito,
2000), the formation of such structures will also inevitably
increase the local concentration of mutant SOD1 protein and
associated proteins. As the proteasome has been implicated as a
crucial regulator of multiple essential cellular processes, includ-
ing gene expression, apoptosis, the cell cycle, development, and
DNA repair (for review see Wolf and Hilt, 2004), aberrant inter-
actions initiated by aggregate formation may result in the dys-
regulation of numerous pathways critical to cell survival.
The appearance of mutant SOD1 aggregates in mouse
models of fALS (Bruijn et al., 1997; Johnston et al., 2000; Wa-
tanabe et al., 2001; Wang et al., 2002) and in tissue samples
from patients (Shibata et al., 1996; Kato et al., 2000) has sug-
gested a role for aggregation in cellular toxicity. However, other
observations with mutant SOD1 (A4V and V148G) have con-
cluded that aggregate formation does not correlate with neu-
ronal death in differentiated PC12 cells (Lee et al., 2002). In an
effort to address this, we performed time-lapse experiments to
follow the fate of individual differentiated PC12 cells express-
ing mutant SOD1 and showed that cell death correlates with an
increased levels of mutant SOD1 protein and the formation of
aggregates and occurs within 6 to 24 h after aggregates are visu-
ally detected. At any given time-point, only a small fraction
(20–30%) of mutant SOD1-expressing cells has visible aggre-
gates. Such variation may be due to the intrinsic heterogeneity
of transient or stably expressing cell lines or perhaps due to dif-
ferential levels of protein expression and cell-to-cell variation in
protein homeostasis. If only these aggregate-containing cells are
marked for cell death within the subsequent 24-h time period,
the overall percentage of cells undergoing cell death at any sin-
gle time point is much smaller, yet for the fraction of cells with
aggregates, nearly all are destined for cell death. Moreover, as
these aggregate-containing cells die, they are replaced by other
cells that express aggregates. Using live-cell time-lapse micros-
copy, we are able to demonstrate the rapid cell death that ensues
upon appearance of mutant SOD1 aggregates and clearly show
that aggregate formation leads to cell death. Whereas aggregate-
containing PC12 cells died rapidly, in contrast, 70% of cells
with diffuse mutant SOD1 remained viable over the 120-h ex-
perimental period. A recent observation with cells containing
huntingtin aggregates showed survival for more than 120 h and
that aggregate-containing cells even exhibited a reduced risk for
cell death (Arrasate et al., 2004). Even though some of these
differences can be attributed to various technical differences
(i.e., level of protein overexpression, cell type, method of detec-
tion/characterization), our studies on mutant SOD1 aggregates
clearly indicate a direct link to neuronal cell death.
Materials and methods
Constructs
The pEYFP-N1-Hsp70 and the Hsp70 substrate binding domain deletion
mutant (Hsp70-SBDx-YFP) were previously described (Kim et al., 2002).
The pEYFP-N1-LMP2, pTRE2hyg-HttQ78-CFP, and pEYF-N1-Ubi-YFP con-
structs were previously described (Holmberg et al., 2004). The pTRE-YFP
or pTRE-CFP vectors were generated by PCR amplification of YFP from
pEYFP-N1 or CFP from pECFP-N1 (CLONTECH Laboratories, Inc.) and
subcloning into the pTRE2hyg (CLONTECH Laboratories, Inc.). pTRE-
SOD1-WT-YFP, pTRE-SOD1-WT-CFP, pTRE-SOD1-G85R-YFP, and pTRE-
SOD1-G85R-CFP were generated by PCR amplification of WT SOD1 and
G85R mutant SOD1 from plQL01 or plQL03 (gift from Dr. Q. Liu, Harvard
Medical School, Boston, MA), respectively, and inserting into pTRE-YFP or
pTRE-CFP. pTRE-SOD1-G93A-YFP and pTRE-SOD1-G93A-CFP were gener-
ated by PCR-based site-directed mutagenesis at G93A of pTRE-SOD1-WT-
YFP or pTRE-SOD1-WT-CFP. All constructs were verified by sequencing.
Cell culture and transfection
PC12 Tet-Off cells (CLONTECH Laboratories, Inc.) were maintained in
DME supplemented with 10% heat-inactivated horse serum, 100 U/ml
penicillin, 100  g/ml streptomycin, and 100  g/ml G418 at 37 C in a
5% CO2-humidified atmosphere. PC12 Tet-Off cells were differentiated
with 100 ng/ml nerve growth factor (Sigma-Aldrich) for 7 d and were
continuously maintained in medium containing nerve growth factor for the
remainder of all studies, as previously described (Vignali et al., 1996).
For colocalization studies, cells were grown in Matrigel-coated (BD Bio-
sciences) two-well glass slide chambers (Lab-Tek). For live cell analysis,
cells were grown in Matrigel-coated 35-mm glass-bottom dishes (MatTek
Corp.). Transient transfections were performed using LipofectAmine-PLUS
reagent using twice the manufacturer-recommended volume and 3  g of
SOD1 DNA constructs. Cotransfection of pEYFP-N1-Hsp70 with the SOD1
constructs was performed at a ratio of 1:10 (Hsp70/SOD1) and of pEYFP-
N1-LMP2 at 1:3 (LMP2/SOD1). Ubi-YFP/PC12 cells were generated by
cotransfecting PC12 Tet-Off cells with the pEYFP-N1-Ubi-YFP construct and
a puromycin-resistance pBSpac p construct (gift from Dr. Y. Minami, Osaka
University, Osaka, Japan), using LipofectAmine-PLUS (Invitrogen) and se-
lecting with 2.5  g/ml puromycin.
Western analysis
Transfected PC12 cells were harvested, resuspended in 20 mM Hepes,
pH 7.9, with 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, and 1 mM PMSF and lysed using freeze–thaw. Total protein
amount was quantitated using a Bradford protein assay (Bio-Rad Laborato-
ries). Protein lysates (10  g) were resuspended in SDS sample buffer and
loaded onto a 12.5% SDS-PAGE gel. The gel was transferred to a nitrocel-
lulose membrane and immunoblotted using an IRDye 800-fused anti-GFP
antibody (600–132-215; Rockland Immunochemicals, Inc.) to detect CFP-
or YFP-fused proteins. As a loading control,  -tubulin was detected using
an anti– -tubulin antibody (GTU-88; Sigma-Aldrich). Primary antibodies
were detected with an anti–mouse Alexa Fluor 680-conjugated secondary
antibody (Invitrogen). Blots were analyzed using an Odyssey infrared im-
aging system (LI-COR Bioscience).
SOD1 activity assay
The same protein lysates (15  g) used for Western analysis, were loaded
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(Sigma-Aldrich) solution at room temperature for 15 min (in the dark, as
riboflavin is light sensitive). After removal of riboflavin-NBT, the gel was
incubated with 0.1% TEMED for 15 min and exposed to light, to induce
superoxide synthesis.
Filter-trap assay
The same protein lysates (100  g) used for Western analysis, were resus-
pended in a 1% SDS solution in PBS, and loaded onto a cellulose acetate
membrane (0.2  m; Advantec MFS, Inc.). The membrane was washed with
1% SDS in PBS and protein was detected as per Western blotting protocol.
Visualization of fluorescently tagged proteins
Transfected PC12 cells were fixed in 4% formaldehyde in PBS for 10 min,
quenched in 0.1 M Tris-HCl, pH 8.0, for 5 min, washed in PBS at room
temperature, and mounted in Vectashield antifading solution (Vector Labo-
ratories). Fixed samples were examined using a Leica TCS SP2/Leica DM-
IRE2 inverted confocal microscope equipped with 63  oil objective lens
(Leica). Approximately 300 different transfected cells were scored, in three
independent experiments, for aggregate formation. For measurement of
LMP2 relocalization, a whole-cell Z stack (each slice   0.5  m) was ac-
quired, a maximum projection created, and whole-cell intensity of LMP2-
YFP measured against the intensity localized to the aggregate (n   7 differ-
ent cells). For live-cell imaging, transfected PC12 cells were maintained at
37 C for the duration of the experiment. Photobleaching for FRAP and FLIP
analyses was performed as described previously (Kim et al., 2002; Holm-
berg et al., 2004), using a Zeiss LSM 510 Meta Axiovert confocal micro-
scope (Carl Zeiss MicroImaging Inc.) and a 40  oil objective lens (FRAP)
and a Leica TCS SP2/Leica DM-IRE2 inverted confocal microscope and a
63  oil objective lens (FLIP). The 514-nm laser wavelength was used at
100% laser power in photobleaching of the YFP fusion proteins. For FRAP
analysis, single-scan images were taken at 5  zoom power and an area
of 12.5  m
2 was bleached for 3 s (20 iterations), after which an image
was collected every 3 s. For FLIP analysis, a single image was taken at 4 
zoom power and an area of 8.4  m
2 was bleached away from the aggre-
gate. Subsequently, images were collected every 30 s during continuous
photobleaching. Average fluorescence intensities for FRAP and FLIP were
determined using Metamorph software (Universal Imaging Corp.). Relative
fluorescence intensities (RFI) for FRAP and FLIP were calculated using RFI  
([Net/N1t]/[Ne0/N10])   100, as previously described (Kim et al., 2002;
Holmberg et al., 2004). FRAP data were fit as described in Online supple-
mental materials. FLIP data were fit with GraphPad Prism (GraphPad Soft-
ware), using a two-phase exponential decay method, which yielded a bet-
ter curve fit than a one-phase exponential decay method. All images were
processed by Adobe Photoshop software (Adobe Systems Inc.).
Ubi-YFP reporter assay
Differentiated Ubi-YFP/PC12 cells were transfected with indicated con-
structs and 72 h later, the cells were fixed and examined using a Zeiss Ax-
iovert 200 inverted microscope equipped with a 20  objective lens, CFP
(ex 436/20, em 480/40), and a YFP (ex 500/20, em 535/30) filter set
(Carl Zeiss MicroImaging, Inc.). YFP intensities in nuclei of individual trans-
fected or nontransfected cells were measured using Metamorph software.
Time-lapse survival assay
PC12 cells were transfected with constructs and 72 h later, analyzed us-
ing time-lapse microscopy. Cells were maintained at 37 C, with a 5%
CO2 live-cell incubation chamber, for the duration of the experiment. Im-
aging was performed on a Zeiss Axiovert 200 inverted microscope,
equipped with a 20  objective lens, an objective heater, and an electro-
mechanical stage for automated x, y, and z positioning. Images at 15–20
different sites were acquired at 2–3 h intervals, during a 48-h period. For
each site, seven different Z planes (2  m) were acquired to account for
cellular movement in the Z plane. Images were acquired of the FITC chan-
nel (YFP-fused proteins), Texas red channel (PI; Sigma-Aldrich), and DIC.
After the 48-h period, images were aligned into a time-lapse animation us-
ing Zeiss AxioVision imaging software. Individual cells were followed
over the 48-h period and scored for time of aggregate appearance and
cell death, according to morphological change or PI staining. Over 200
individual cells, for each construct, were scored over three independent
experiments. All images were processed by Adobe Photoshop software.
Statistical analysis
GraphPad Prism software was used to fit all curves and determine statisti-
cal values. All data are depicted as mean   SEM. Two-tailed t test analysis
(95% confidence) was used to compare the statistical difference between
data sets, where applicable.
FRAP curve fitting and mathematical modeling
Two empirical formulas, one described by Ellenberg et al. (1997) and Lip-
pincott-Schwartz et al. (2001),
(1)
and a second described by Axelrod et al. (1976),
(2)
have been commonly used for fitting FRAP data and the determination
of diffusion coefficients. However, neither of these equations yielded a
completely satisfactory fit to our experimental data, suggesting that
these proteins exhibit a behavior that cannot be explained solely by dif-
fusion, rather also involves either the formation of higher-order com-
plexes or binding interactions with one or more cytoplasmic macromole-
cules or structures. To incorporate such interactions into an optimal,
biologically significant mathematical model of the mobility of WT and
mutant SOD1-YFP proteins, we fit FRAP data using a recently described
biphasic recovery equation by Carrero et al. (2004; see equation 53
therein),
(3)
characterized by a fast recovery phase produced by a fraction 1/(1   k)
of the protein population diffusing rapidly with a diffusional transfer coeffi-
cient Dt, and a slow recovery phase produced by the “turnover” of a frac-
tion k/(1   k) of the protein population bound with an unbinding (off) rate
ku. All FRAP curves were fit with equation 3, using GraphPad Prism soft-
ware (GraphPad Software), yielding satisfactory fits with residual mean
squares s
2   0.0006 s
 1. We then used the relationship by Carrero et al.
(2004),
(4)
to calculate the diffusion coefficient D from the experimentally derived dif-
fusional transfer coefficient Dt. From the diffusion coefficients, we have ap-
plied the Stokes-Einstein formula,
(5)
where the Boltzmann constant k, the viscosity of the solution  , and tem-
perature T all remained constant throughout our studies, to yield a rela-
tionship between the diffusion coefficient and the Stokes’ radius of the
molecule, D   Rh
 1. Assuming that the molecule in question is a sphere
with a Stokes’ radius Rh and a volume proportional to its molecular
weight, we can relate the diffusion coefficient to molecular weight by D  
M
 1/3. As WT SOD1 forms a highly stable homodimer, we expect WT-
SOD1 fused to YFP to form a complex with a molecular weight of  90
kD. Using D   M
 1/3 or where C is a constant to be calculated, and the
experimentally derived diffusion coefficients (Table I), we approximated
the average molecular weights resulting in the reduced diffusion for each
protein population.
(6)
Immunofluorescence analysis
The protocol for visualization of the 20-s endogenous proteasome was
performed as previously described (Holmberg et al., 2004).
Online supplemental material
Fig. S1 shows mutant SOD1 aggregates retain similar properties in non-
neuronal cells. Fig. S2 demonstrates WT-YFP also diffuses through mu-
tant SOD1 aggregates. Fig. S3 shows that mutant SOD1 aggregates af-
fect the localization of endogenous proteasome. Video S1 depicts how
PC12 cells forming mutant SOD1 aggregates die rapidly. Online supple-
mental materials are available at http://www.jcb.org/cgi/content/full/
jcb.200504050/DC1.
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